Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LEPR Polymorphism and Mirtazapine Weight Gain in Late Life Depression
NCT01601002Phase 4Completed
- Start
- Jun 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of mirtazapine in major depressive disorder (MDD). Started Jun 2012; status: completed.
02
Drugs
mirtazapine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01601002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01601002.